A Therapeutic Vaccine for Fibrolamellar Hepatocellular Carcinoma
Demographics (3)
- AGE - Subject age at enrollment (phv00565234.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00565240.v1.p1)
- SEX - Biological sex (phv00565229.v1.p1)
Disease Events (6)
- IS_TUMOR - Tumor status (phv00565238.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00565241.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00565242.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00565244.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00565243.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00565245.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00565233.v1.p1)
Other (10)
- ANALYTE_TYPE - Analyte Type (phv00565237.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00565236.v1.p1)
- CONSENT - Registered consent groups (Data Use Limitations (DUL)) as determined by submitters' Institutional Review Boards (IRB) or equivalent body. (phv00565228.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00565239.v1.p1)
- RESPONSE - Response to treatment (phv00568564.v1.p1)
- SAMPLE_ID - Sample ID (phv00565235.v1.p1)
- SAMPLE_ID - Sample ID (phv00565231.v1.p1)
- SUBJECT_ID - Subject ID (phv00565232.v1.p1)
- SUBJECT_ID - Subject ID (phv00565227.v1.p1)
- SUBJECT_ID - Subject ID (phv00565230.v1.p1)